Dementia with Lewy bodies: prevalence, clinical spectrum and natural history

  • G. Ransmayr
Conference paper


The article summarises history, terminology, the clinical and neuropathological diagnostic criteria, neurochemical and genetic findings, sensitivity and specificity of the clinical diagnostic criteria, prevalence, demographical data and nosology, differential diagnosis, and therapy of dementia with Lewy bodies (DLB). DLB shares clinical symptoms of Parkinson’s disease and dementia of the Alzheimer-type (DAT). However, DLB is also different to PD and DAT (less tremor and asymmetry of the motor symptoms, more falls, and less favourable response to L-Dopa than PD; in contrast to DAT marked cognitive fluctuations and phases of reduced alertness, hallucinations and delirium). There are genetic similarities to DAT and PD in terms of common genetic risk factors. A genetic cause of the disease has so far not been detected. Whether or not DLB is a disease entity or an association of diseases (Lewy body disease and DAT) has so far not been elucidated. Clinical distinction from DAT and PD has clinical importance because of different therapeutic and prognostic implications. Studies are needed to standardize the treatment of motor, cognitive, psychiatric and vegetative symptoms.


Lewy Body Dementia With Lewy Body Senile Dementia Lewy Body Disease Clinical Diagnostic Criterion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aarsland D, Bronnick K, Karlsen K (1999) Donepezil for dementia with Lewy bodies: a case study. Int J Geriatr Psychiatry 14: 69–72PubMedCrossRefGoogle Scholar
  2. Albin RL, Minoshima S, D’Amato CJ, Frey KA, Kuhl DA, Sima AAF (1996) Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 47: 462–466PubMedCrossRefGoogle Scholar
  3. Atkinson A, Singleton AB, Steward A, Ince PG, Perry RH, McKeith IG, Fairbairn AH, Edwardson JA, Daly AK, Morris CM (1999) CYP associated with Parkinson’s disease but not with dementia with Lewy bodies or Alzheimer’s disease. Pharmacogenetics 9: 31–35PubMedCrossRefGoogle Scholar
  4. Ballard C, Holmes C, McKeith I, Neill D, O’Brien J, Cairns N, Lantos P, Perry E, Ince P, Perrry R (1999) Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer’s disease. Am J Psychiatry 156: 1039–1045PubMedGoogle Scholar
  5. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O’Brien JT (1999) Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 52: 1153–1158PubMedCrossRefGoogle Scholar
  6. Boeve BF, Silber MH, Ferman TJ, Kokmen E, Smith GE, Ivnik RJ, Parisi JE, Olson EJ, Petersen RC (1998) REM sleep behavior disorder and degenerative dementia: an association likely reflects Lewy body disease. Neurology 51: 363–370PubMedCrossRefGoogle Scholar
  7. Briel RCG, McKeith IG, Barker WA, Hewitt Y, Perry RH, Ince PG, Fairbairn AF (1999) EEG findings in dementia with lewy bodies and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 66: 401–403PubMedCrossRefGoogle Scholar
  8. Brown DF, Dababo MA, Bigio EH, Risser RC, Eagan KP, Hladik CL, White CL 3rd (1998) Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol 57: 39–46PubMedCrossRefGoogle Scholar
  9. Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA (1988) Diffuse Lewy body disease and progressive dementia. Neurology 38: 1520–1528PubMedCrossRefGoogle Scholar
  10. Byrne EJ, Lowe J, Godwin-Austen RB, Arie T, Jones R (1987) Dementia and Parkinson’s disease associated with diffuse cortical Lewy bodies. Lancet is 501Google Scholar
  11. Candy JM, Perr RH, Perry EK, Irving D, Blessed G, Fairbairn AF, Tomlinson BE (1983) Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s diseases. J Neurol Sci 54: 277–289CrossRefGoogle Scholar
  12. Cercy SP, Bylsma FW (1997) Lewy bodies and progressive dementia: A critical review and meta-analysis. J Int Neuropsychol Soc 3: 179–194PubMedGoogle Scholar
  13. Del-Ser, Munoz DG, Hachinski V (1996) Temporal pattern of cognitive decline and incontinence is different in Alzheimer’s disease and diffuse Lewy body disease. Neurology 46: 682–686PubMedCrossRefGoogle Scholar
  14. Dickson DW, Davies P, Mayeux R, Crystal H, Horoupian DS, Thompson A, Goldman JE (1987) Diffuse Lewy body disease: Neuropathological and biochemical studies of six patients. Acta Neuropathol 75: 8–15PubMedCrossRefGoogle Scholar
  15. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress A, Yen SH (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: Light and electron microscopic immunocytochemistry of CA2–3 neurites specific to DLBD. Neurology 41: 2–3PubMedCrossRefGoogle Scholar
  16. Ditter SM, Mirra SS (1987) Neuropathologic and clinical features of Parkinson’s disease in Alzheimer’s disease patients. Neurology 29: 1209–1214Google Scholar
  17. Donnemiller E, Heilmann J, Wenning GK, Berger W, Decristoforo C, Moncayo R, Poewe W, Ransmayr G (1996) Brain perfusion scintigraphy with 99mTc-HMPAO or 99Tc-ECD and 1231-ß-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med 24: 320–325Google Scholar
  18. Drach LM, Steinmetz HE, Wach S, Bohl J (1997) High proportion of dementia with Lewy bodies in the postmortems of a mental hospital in Germany. Int J Geriatr Psychiatry 12: 301–306PubMedCrossRefGoogle Scholar
  19. Forno LS, Barbour PJ, Norville RL (1978) Presenile dementia with Lewy bodies and neurofibrillary tangles. Arch Neurol 35: 818–822PubMedCrossRefGoogle Scholar
  20. Galasko D, Saitoh T, Xia T (1995) The apolipoprotein E allele e4 is over-represented in patients with the Lewy body variant of Alzheimer’s disease. Neurology 44: 1950–1951CrossRefGoogle Scholar
  21. Galasko D, Katzman R, Salmon DP, Hansen L (1996) Clinical and neuropathological findings in Lewy body dementias. Brain Cogn 31: 166–175PubMedCrossRefGoogle Scholar
  22. Gearing M, Lynn M, Mirra SS (1999) Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups. Arch Neurol 56: 203–208PubMedCrossRefGoogle Scholar
  23. Gibb WRG, Esiri MM, Lees AJ (1985) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110: 1131–1153CrossRefGoogle Scholar
  24. Gnanalingham KK, Byrne EJ, Thornton A, Sambrook MA, Bannister P (1997) Motor and cognitive function in Lewy body dementia: comparison with Alzheimer’s and Parkinson’s diseases. J Neurol Neurosurg Psychiatry 62: 243–252PubMedCrossRefGoogle Scholar
  25. Gomez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT (1999) Clinical and quantitative pathological correlates of dementia with Lewy bodies. Neurology 53: 1284–1291PubMedCrossRefGoogle Scholar
  26. Hansen LA, Samuel W (1997) Criteria for Alzheimer’s disease and the nosology of dementia with Lewy bodies. Neurology 48: 126–132PubMedCrossRefGoogle Scholar
  27. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford M (1990) The Lewy body variant of Alzheimer’s disease: A clinical and pathological entity. Neurology 40: 18Google Scholar
  28. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM (1994) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types: Significance for etiological theories of Alzheimer’s disease. Am J Pathol 1472–1484.Google Scholar
  29. Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, Tanimukai S, Hanihara T, Mori E (1998) Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology 51: 357–362PubMedCrossRefGoogle Scholar
  30. Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh-Bohmer KA, Peterson B, Pieper C (1999) Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease. Neurology 52: 1839–1844PubMedCrossRefGoogle Scholar
  31. Higuchi S, Arai H, Matsushita S, Matsui, Kimpara T, Takeda A, Shirakura K (1998) Mutation in the alpha-synuclein gene and sporadic Parkinson’s disease, Alzheimer’s disease, and dementia with Lewy bodies. Exp Neurol 153: 164–166PubMedCrossRefGoogle Scholar
  32. Holmes C, Cairns N, Lantos P, Mann A (1999) Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174: 45–50PubMedCrossRefGoogle Scholar
  33. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) The accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinicopathological study. J Neurol Neurosurg Psychiatry 55: 181–184PubMedCrossRefGoogle Scholar
  34. Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clark C (1995) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part IX. A prospective cliniconeuropathological study of Parkinson’s features in Alzheimer’s disease. Neurology 45: 1991–1995PubMedCrossRefGoogle Scholar
  35. Ikeda K, Yoshimura, T, Kato H, Namba M (1978) Idiopathic parkinsonism with Lewy-type inclusions in cerebral cortex. A case report. Acta Neuropathol 41: 165168CrossRefGoogle Scholar
  36. Ikeda K, Hori A, Boe G (1980) Progressive dementia with diffuse Lewy-type inclusions in cerebral cortex: A case report. Arch Psychiatr Nervenkr 228: 243–248PubMedCrossRefGoogle Scholar
  37. Imamura T, Hirono N, Hashimoto M, Shimomura T, Tanimukai S, Kazui H, Hanihara T, Mori E (1999) Clinical diagnosis of dementia with Lewy bodies in a Japanese Dementia Registry. Dement Geriatr Disord 10: 210–216CrossRefGoogle Scholar
  38. Ince PG, Irving D, McArthur F, Perry RH (1991) Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson’s disease and non-demented elderly control patients. J Neurol Sci 106: 142–152PubMedCrossRefGoogle Scholar
  39. Ince PG, Perry EK, Morris CM (1998) Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol 8: 299–324PubMedCrossRefGoogle Scholar
  40. Ishii K, Yamaji S, Kitagaki H, Imamura T, Hirono N, Mori E (1999) Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 53: 413–416PubMedCrossRefGoogle Scholar
  41. Ishikawa A, Takahashi H, Tanaka H, Hayashi T, Tsuji S (1997) Clinical features of familial diffuse Lewy body disease. Eur Neurol 38: 34–38PubMedCrossRefGoogle Scholar
  42. Jellinger KA (1999) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 18: 214–215PubMedGoogle Scholar
  43. Kaufer DI, Catt KE, Lopez OL, DeKosky ST (1998) Dementia with Lewy bodies: response of delirium-like features to donepezil. Neurology 51: 1512PubMedCrossRefGoogle Scholar
  44. Klatka LA, Louis ED, Schiffer RB (1996) Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer’s disease and Parkinson’s disease comparison groups. Neurology 47: 1148–1152PubMedCrossRefGoogle Scholar
  45. Kosaka K (1978) Lewy bodies in cerebral cortex. Report of three cases. Acta Neuropathol (Berl) 42: 127–134CrossRefGoogle Scholar
  46. Kosaka K (1990) Diffuse Lewy body disease in Japan. J Neurol 237: 197–204PubMedCrossRefGoogle Scholar
  47. Kosaka K, Mehraein P (1979) Dementia-parkinsonism syndrome with numerous Lewy bodies and senile plaques in cerebral cortex. Arch Psychiatr Nervenkrankh 226: 241–250CrossRefGoogle Scholar
  48. Kosaka K, Matsushita M, Oyanagi S, Mehraein P (1980) A cliniconeuropathological study of the “Lewy body disease”. Psychiatr Neurol Jpn 5: 292–311Google Scholar
  49. Kosaka K, Yoshimura M, Ikeda K, Budka H (1983) Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree: a new disease? Clin Neuropathol 3: 185–92Google Scholar
  50. Kosaka K, Yoshimura M, Ikeda K, Budka H (1984) Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree—a new disease? Clin Neuropathol 3: 185–192PubMedGoogle Scholar
  51. Lamb H, Christie J, Singleton AB, Leake A, Perry RH, Ince PG, McKeith IG, Melton LM, Edwardson JA, Morris CM (1998) Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer’s disease and in dementia with Lewy bodies. Distinctions between diseases. Neurology 50: 388–391Google Scholar
  52. Langlais PJ, Thal L, Hansen LA (1993) Neurotransmitters in basal ganglia and cortex of Alzheimer’s disease with and without Lewy bodies. Neurology 43: 1927–1934PubMedCrossRefGoogle Scholar
  53. Lebert F, Pasquier F, Souliez L, Petit H (1998) Tacrine efficacy in Lewy body dementia. Int J Geriatr Psychiatr 13: 516- 519CrossRefGoogle Scholar
  54. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB (1989) Diffuse Lewy body disease: Correlative neuropathology using anti- ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatr 52: 1236–1247PubMedCrossRefGoogle Scholar
  55. Levy R, Eagger S, Griffiths M, Perry E, Honavar M, Dean A, Lantos P (1994) Lewy bodies and response to tacrine in Alzheimer’s disease. Lancet 343: 176PubMedCrossRefGoogle Scholar
  56. Lewy FH (1923) Die Lehre vom Tonus and der Bewegung: Zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie and Pathogenese der Paralysis agitans. Springer, BerlinGoogle Scholar
  57. Lindboe CF, Hansen HB (1998) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 17: 204–209PubMedGoogle Scholar
  58. Lippa CF, Smith TW, Swearer JM (1994) Alzheimer’s disease and Lewy body disease: a comparative clinicopathologic study. Ann Neurol 35: 81- 88PubMedCrossRefGoogle Scholar
  59. Lippa CF, Smith TW, Saunders AM, Crook R, Pulaski-Salo D, Davies P, Hardy J, Roses AD, Dickson D (1995) Apolipoprotein E genotype and Lewy body disease. Neurology 45: 97–103Google Scholar
  60. Lippa CF, Smith TW, Perry E (1999) Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology. J Neural Transm 106: 525–535Google Scholar
  61. Litvan I, Maclntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chauduri KR, Lai EC, D’Olhaberriague L, Pearce RK, Agid Y (1997) Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 55: 969–978CrossRefGoogle Scholar
  62. Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST (1999) Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 53: 1292–1299PubMedCrossRefGoogle Scholar
  63. Louis ED, Klatka LA, Liu Y, Fahn S (1997) Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson’s disease. Neurology 48:376–380PubMedCrossRefGoogle Scholar
  64. Luis CA, Barker WW, Gajaray K, Harwood D, Petersen R, Kashuba A, Waters C, Jimison P, Pearl G, Petito C, Dickson D, Duara R (1999) Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry 14: 526–533PubMedCrossRefGoogle Scholar
  65. Mattila PM, Roytta M, Torikka H, Dickson DW, Rinne JO (1998) Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease. Acta Neuropathol 95: 576–582PubMedCrossRefGoogle Scholar
  66. Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cotè LJ, Stern Y (1992) A population based investigation of Parkinson’s disease with and without dementia. Relationship to age and gender. Arch Neurol 49:492–497PubMedCrossRefGoogle Scholar
  67. McKeith IG, Fairbaim AF, Bothwell RA, Moore PB, Ferrier IN, Thompson P, Perry RH (1994a) An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 44: 872–877CrossRefGoogle Scholar
  68. McKeith IG, Fairbairn AF, Perry RH, Thompson P (1994b) The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry 165: 324–332Google Scholar
  69. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA et al. (1996) Consensus guidlines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 47: 1113–1124PubMedCrossRefGoogle Scholar
  70. McKeith IG, Perry EK, Perry RH (1999) Report of the second dementia with Lewy body international workshop. Neurology 53: 902–905PubMedCrossRefGoogle Scholar
  71. Mega MS, Masterman DL, Benson DF, Vinters HV, Tomiyasu U, Craig AH, Foti DJ, Kaufer D, Scharre DW, Fairbanks L, Cummings J (1996) Dementia with Lewy bodies: Reliability and validity of clinical and pathological criteria. Neurology 47: 1403–1409PubMedCrossRefGoogle Scholar
  72. Ohara K, Takauchi S, Kokai M, Morimura Y, Nakajima T, Morita Y (1999) Familial dementia with Lewy bodies. Clin Neuropathol 18: 232–239PubMedGoogle Scholar
  73. Okazaki H, Lipkin LE, Aronson SM (1961) Diffuse intracytoplasmic ganglionic inclusions (lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 20: 237–244PubMedCrossRefGoogle Scholar
  74. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ (1996) The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer’s disease and Lewy body variant. Neurology 47: 190–196Google Scholar
  75. Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer’s disease. Neurology 51: 351–357PubMedCrossRefGoogle Scholar
  76. Opeskin K, Gonzales M, Borenstein R, Anderson R (1993) Diffuse Lewy body disease with immediate post-partum onset. Acta Neuropathol 85: 213 -216PubMedCrossRefGoogle Scholar
  77. Perry EK, Smith CJ, Court JA, Perry RH (1990) Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J Neural Transm Park Dis Dement Sect 2(3): 149–158PubMedCrossRefGoogle Scholar
  78. Perry EK, Haroutunian V, Davis KL (1994) Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer’s disease. Neuro Report 5: 747–749Google Scholar
  79. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of the Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95: 119–139PubMedCrossRefGoogle Scholar
  80. G. Ransmayr: Dementia with Lewy bodiesGoogle Scholar
  81. Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK (1999) Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer’s and Parkinson’s diseases:rostrocaudal distribution. Brain 122: 1449–1468PubMedCrossRefGoogle Scholar
  82. Sahgal A, Galloway PH, McKeith IG, Lloyd S, Cook JH, Ferrier IN, Edwardson JA (1992) A comparative study of attentional deficits in senile dementias of Alzheimer and Lewy body types. Dementia 3: 350–354Google Scholar
  83. Samuel W, Alford M, Hofstetter R, Hansen L (1997) Dementia with Lewy bodies versus pure Alzheimer Disease: Differences in cognition, neuropathology, cholinergic dysfunction, an synapse density. J Neuropath Exp Neurology 56: 499–508CrossRefGoogle Scholar
  84. Shimomura T, Mori E, Yamashita H, Imamura T, Hirono N, Hashimoto M, Tanimukai S, Kazui H, Hanihara T (1998) Cognitive loss in dementia with lewy bodies and Alzheimer disease. Arch Neurol 55: 1547–1552PubMedCrossRefGoogle Scholar
  85. St. Clair D, Norrman J, Perry R, Ytes C, Wilcock G, Brookes A (1994) Apolipoprotein E E4 allele frequency in patients with Lewy body dementia, Alzheimer’s disease and age-matched controls. Neurosci Lett 176: 45–46Google Scholar
  86. Tanaka S, Chen X, Xia Y, Kang DE, Matoh N, Sundsmo M, Thomas RG, Katzman R, Thal LJ, Trojanowski JQ, Saitoh T, Ueda K, Masliah E (1998) Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer’s disease. Neurology 50: 1556–1562PubMedCrossRefGoogle Scholar
  87. Trètiakoff C (1919) Contribution à l’ètude de l’anatomie pathologique du locus niger de Soemmering. Thèse, Paris Nr. 293Google Scholar
  88. Verghese J, Crystal HA, Dickson DW, Lipton RB (1999) Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurlogy 53: 1974–1982CrossRefGoogle Scholar
  89. Wakabayashi K, Hayshi S, Ishikawa A, Hayshi T, Okuizumi K, Tanaka H, Tsuji S, Takahashi H (1998) Autosomal dominant diffuse Lewy body disease. Acta Neuropathol (Berl) 96: 207–210CrossRefGoogle Scholar
  90. Walker Z, Grace J, Overshot R, Satarasinghe S, Swan A, Katona CL, McKeith IG (1999) Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry 14: 459–466PubMedCrossRefGoogle Scholar
  91. Weiner MF, Risser RC, Cullum CM, Horrig L, Withe III C, Speziale S, Rosenberg RN (1996) Alzheimer’s disease and its Lewy body variant: A clinical analysis of postmortem verified cases. Am J Psychiatry 153: 1269–1273PubMedGoogle Scholar
  92. Yoshimura M (1983) Cortical changes in the parkinsonian brain: a contribution to the delineation of “diffuse Lewy body disease”. J Neurol 229: 17–32PubMedCrossRefGoogle Scholar
  93. Author’s address: Dr. G. Ransmayr, Department of Neurology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck,AustriaGoogle Scholar

Copyright information

© Springer-Verlag Wien 2000

Authors and Affiliations

  • G. Ransmayr
    • 1
  1. 1.Department of NeurologyUniversity of InnsbruckInnsbruck

Personalised recommendations